Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1/plasminogen activator interaction.

Sillen, Machteld

Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1/plasminogen activator interaction. [electronic resource] - Journal of thrombosis and haemostasis : JTH 03 2020 - 681-692 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1538-7836

10.1111/jth.14716 doi


Humans
Plasminogen Activator Inhibitor 1
Plasminogen Activators
Single-Domain Antibodies
Tissue Plasminogen Activator
Urokinase-Type Plasminogen Activator
Vitronectin